At Monday evening’s plenary debate of the European Parliament, the security of Europe’s pharmaceutical supply was at the center of the discussion. Military conflicts, the worsening energy crisis, and the vulnerability of global supply chains have once again highlighted that Europe must reduce its dependence on third countries in the area of critical medicines and pharmaceutical active ingredients, stated Viktória Ferenc, member of the Fidesz–KDNP delegation and representative of the Patriots for Europe group.

In her speech, Viktória Ferenc welcomed the political agreement reached on the Critical Medicines Act, while stressing that European solidarity cannot be limited solely to joint procurement mechanisms. Member States that contribute to Europe’s security of supply through strong pharmaceutical industries, research capacities, and manufacturing expertise must also receive support.

Hungary is among these countries, playing a strategic role in pharmaceutical innovation and manufacturing, and remains committed to contributing to Europe’s health sovereignty. However, this requires a competitive regulatory environment, proportionate environmental requirements, and genuine industrial policy support, because European patients do not need promises—they need reliable access to life-saving medicines.

Europe’s pharmaceutical industry needs reasonable and predictable environmental and industrial rules that simultaneously protect the environment, guarantee supply for citizens, and strengthen the sector’s competitiveness –  the member added following the debate.

20 May 2026, Strasbourg